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Summary. We assessed 20 shoulders with rotator cuff tendinopathy and partial tendon tears treated with 
FIT® plasters (far infrared technology). The criteria for inclusion were pain at night and during active shoul-
der movement. Patients with restricted passive movement (adhesive capsulitis) and complete tendon tears 
were excluded. Two different types of FIT® plasters were used according to the different power of action. 
Plasters were replaced after 7 days and dismissed after 15 days. The patients were assessed using the VAS pain 
scale and the Constant Murley score for function. The use of FIT® plasters have shown a certain effectiveness 
in activation of the endogenous analgesic action, with a role in alleviate painful symptoms and improve func-
tion in rotator cuff tendinopathies, without adverse events. On the base of the safety of this technology and 
promising results of our study, further studies should be encouraged to confirm its effectiveness, increasing 
the sample number and follow up so as to demonstrate definitely that the use of technologies, on which FIT® 
plasters is based, may be a valid alternative as “non-medicated pain relief”. (www.actabiomedica.it)
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O r i g i n a l  a r t i c l e
Introduction
Rotator cuff pathology is a common cause of 
shoulder pain. The differential diagnosis includes tend-
initis, tendinopathy, subacromial impingement, com-
plete and partial tendon tear and calcific tendinopathy. 
There is a high incidence of degenerative tendinopathy, 
which can lead to tendon rupture. Torn tendons are 
due to continual injuries as well as work that involves 
repetitive movements. Excessive mechanical loads are 
considered the main causes in these degenerative pro-
cesses.
The aim of conservative treatment, based on phys-
ical therapy, is to reinforce the shoulder muscles such 
as the scapula elevators and the humeral head depres-
sors. To avoid physiotherapy in the initial stages, infra-
red radiation is used in a wavelength that matches the 
body’s own. This technology has already been widely 
studied and used to support the therapy of various 
pathologies or to help improve conditions, also as an 
alternative to pharmacological therapy, which is not 
always effective. Although there is no evidence in lit-
erature on the topical treatment in this type of pathol-
ogy, encouraging results have been reported on the use 
of plasters with nitric oxide derivatives, even though 
the mechanism of action is still be studied (1). 
The purpose of our study is to assess the effec-
tiveness of the FIT® (Far Infrared Technology) plas-
ter, which reflects the “far” infrared radiation (4-21 
micron) emitted by the human body, in the treatment 
of rotator cuff tendinopathy.
Materials and methods
Our study assessed 18 patients (20 shoulders), 10 
males and 8 females, with rotator cuff tendinopathy 
and partial tendon tears treated with FIT® plasters.
The criteria for inclusion were pain at night and 
during active shoulder movement. Patients with re-
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stricted passive movement (adhesive capsulitis) and 
complete tendon tears were excluded.
Two different types of FIT® plasters were used 
according to the different power of action: the most 
potent plasters (conventionally coloured white) were 
used in 10 shoulders and less potent plasters (con-
ventionally coloured black) in other 10 shoulders. In 
each shoulder two plasters of the same type (random 
choice) were applied, 1 in the anterolateral region and 
1 in the posterolateral region under the acromion.
Two pairs of plasters, black on the one and white 
on the other side, were applied to two patients suffer-
ing from bilateral tendinopathies. 
The patients were assessed using the VAS pain 
scale and the Constant Murley score for function.
Plasters were replaced after 7 days and dismissed 
after 15 days.
Clinical assessment was conducted before the 
positioning of plasters and at the end of the topical 
teraphy.
Results
All the patients treated with FIT® plasters had 
an increase in Constant Murley score values except for 
one patient with bilateral tendinopathy whose shoul-
der treated with black plasters recorded the same score 
pre and post application of the plasters. Regarding to 
the VAS pain scale, 4 patients had no improvement (3 
treated with black plasters and 1 treated with white 
plasters) while all the others reported an improvement 
in pain symptoms. 
Analysing all 20 shoulders treated, the Constant 
Murley score average prior to application was 67.05 
points (42-82) and at the end of the teraphy it was 
72.85 points (61-85), showing an average increase of 
5.8 points. The average VAS score prior to application 
was 3.95 (2-7) and at removal it was 2.5 (1-3), with an 
average reduction of 1.45. 
As far as the 10 patients treated with the black 
plaster were concerned, the Constant Murley score av-
erage prior to application was 73 points (56-82) and at 
the end of the teraphy was 76.7 points (62-85), show-
ing an average increase of 3.7 points. The average VAS 
score prior to application was 3.7 (2-6) and at removal 
it was 2.6 (1-3), with an average reduction of 1.1. 
As far as the 10 patients treated with the white 
plaster were concerned, the Constant Murley score 
average prior to application was 61.1 points (42-73) 
and at the end of the teraphy was 69 points (61-78), 
showing an average increase of 7.9 points. The average 
VAS score prior to application was 4.2 (3-7) and at 
removal it was 2.4 (2-3), with an average reduction of 
1.8 (Tab. 1). 
FIT plaster was well tolerated by all patients 
without cases of intolerance.
Discussion
FITs are plasters consisting of 100% non-woven 
polypropylene and an acrylic adhesive mass containing 
a composition of biominerals, in particular metal di-
oxides (including titanium and excluding aluminium), 
which have the property of reflecting the furthest part 
of the light spectrum within the infrared range (be-
tween 4 and 21 mm, with a particular concentration 
around 11 mm). This composition is in powder form 
and is called AT5.05.
FIT® plasters are recommended for relieving sit-
uations of muscular-skeletal discomfort caused by the 
excessive build up of tissue acidosis, from overloading 
the muscular fibres through quicker disposal of lactic 
acid. They are also recommended in functional recov-
ery processes of the muscle tissues affected by contrac-
tion due to overload, antalgic contraction and strength 
deficit from over-stress syndromes as they promote 
relief of the painful symptoms and bring about a myo-
relaxing action on the muscle area in question.
According to recent scientific hypotheses, the 
technology of FIT® plasters can be applied to the hu-
man body by taking advantage of reflected infrared 
radiation, normally emitted by the dispersion of body 
heat, lead to an increase in the skin’s surface microcir-
culation.
There are several studies in literature related to the 
use of infrared radiation in the “organic” wavelength 
range for pathologies and conditions such as dysmen-
orrhea (2, 3), fibromyalgia (4), chronic pain of psy-
chosomatic origin (5), or even simply for obtaining a 
better degree of general wellbeing (6). In the research 
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carried out, only the works related to the applications 
of the far infrared in the therapy of muscular-skeletal 
pain due to causes were selected for the purpose of this 
report.
Although the properties and pathway of infra-
red radiation within the range of organic wavelengths 
has been widely studied, there are, however, very few 
evidence regarding the use of this technology for the 
above-mentioned applications, in support of the inno-
vative nature of these products.
A recent single blind randomized study was car-
ried out on patients with osteoarthritis of the knee (7) 
to evaluate the effectiveness of a plaster containing 
substances with far-infrared emission on the pain and 
on the ultrasound measurement of any joint effusion. 
The patients were randomized into 2 groups, with a 
plaster containing substances with far-infrared emis-
sion applied to the first group and a placebo plaster to 
the second. The primary endpoint of the study was to 
assess improvement in pain after one month of treat-
ment, using the Visual Analogue Scale (VAS); the 
secondary endpoints were the evaluation of the pain 
after one week of treatment and analysis of ultrasound 
results after one month of treatment. While the VAS 
scores both after one week and after one month of 
treatment were comparable (although significantly de-
creased) between the group being treated with plaster 
with far-infrared emission and the placebo group, in 
terms of the ultrasound results in the FIR group there 
was a 40% reduction in the number of patients with 
joint effusions. This reduction was not evident in the 
placebo group, showing that FIR technology may be 
effectively applied as a non-pharmacological alterna-
tive in treating pathologies such as osteoarthritis of the 
knee.
In another double blind randomized study with 
placebo control (8), the effectiveness of FIR radia-
tion on patients with chronic myofascial pain in the 
neck was evaluated. Patients in the treatment group 
wore a collar device containing ceramic powder with 
far-infrared emission (cFIR), while patients in the 
control group wore an inert collar device, both for one 
week. Measurements were taken of the pain intensity 
(through VAS), the quality of sleep, the pressure pain 
threshold (PPT), muscular tone and skin temperature. 
After one week of treatment the intensity of the pain 
was noticeably less in both groups without statistically 
significant differences between the groups. A signifi-
cant difference was, however, recorded in the decrease 
in muscular rigidity, which was better in the treat-
Table 1
Name  Side Pre CMS Post CMS Delta VAS pre VAS post Delta Colour
BA 68 right 72 72 0 3 3 0 black
  left 58 73 15 5 3 -2 white
BR 63 right 69 71 2 2 1 -1 black
  left 42 68 26 7 2 -5 white
CA 52 right 71 74 3 3 2 -1 black
ML 57 right 54 62 8 4 2 -2 white
MM 60 right 57 62 5 4 3 -1 white
RP 62 left 82 85 3 3 3 0 black
ZE 57 right 63 65 2 3 2 -1 white
LL 70 right 76 80 4 4 3 -1 black
RF 66 left 70 77 7 4 2 -2 white
CM 61 left 80 84 4 3 3 0 black
MM 63 left 68 80 12 6 3 -3 black
ML 62 right 60 61 1 5 3 -2 white
DF 58 left 64 68 4 3 2 -1 white
RG 50 left 73 76 3 3 3 0 white
TS 58 right 56 62 6 4 3 -1 black
AF 61 right 82 85 3 5 2 -3 black
BG 64 right 70 78 8 4 2 -2 white
BG 69 left 74 74 0 4 3 -1 black
16-ricci.indd   92 06/04/16   15:04
Use of a non-medicated plaster in shoulder tendinopathies 93
ment with collar with cFIR powder than in the control 
group, leading to the supposition that long-term treat-
ment could be an effective solution for the problem of 
muscular rigidity, which is typical of these disorders.
Wang et al (9) evaluated the analgesic effect of 
FIR radiation on patients during post-operative care 
following complete arthroplasty of the knee. The 41 
patients taking part in the study were randomly as-
signed to the treatment or to the control group. The 
pads of material with FIR technology were positioned 
in various specific therapeutic points on each patients 
in the experimental group from the third to the fifth 
day after the operation. The effectiveness of the anal-
gesia was evaluated using the Numeric Rating Scale 
(NRS) for pain and measuring the serum level of in-
terleukin-6 (IL-6) and endothelin-1 (ET-1). At the 
end of the treatment both the pain and the levels of 
IL-6 and ET-1 were reduced in the group of patients 
treated with FIR.
For all these reasons it is obvious that the use of 
infrared radiation in the body’s infrared wavelength 
is a technology widely studied and used to assist and 
support the therapy of various pathologies or to help 
improve conditions, also as an alternative to pharma-
cological therapy, which is not always effective.
Regarding the technology contained in the FIT® 
plasters, a number of studies have conducted also on 
the powder AT5.05 firstly to assess its properties and 
then with application to human beings to check its ef-
fectiveness in relation to the directions for use declared 
by the manufacturer.
First of all a spectroscopic analysis was carried out 
on the powder at the base of the FIT® plaster technol-
ogy in order to assess its radiance value in the precise 
wavelength range between 2 and 24 mm, which in-
cludes the range of the body’s infrared radiation (16). 
The radiance of the powder within this wavelength 
range was also measured in temperature range between 
25°C and 50°C. These preliminary tests show that the 
radiance of the powder AT5.05 is not only higher than 
the radiance of an infrared opaque medium, but also 
that it increases with the temperature increases and the 
maximum difference in emission is obtained within the 
wavelength range of approximately 9-12 mm (11 mm 
are considered the emission wavelength of the body’s 
infrared radiation).
We completed this pilot study, whose objective 
was to study the application of FIT® plasters in the 
treatment of degenerative rotator cuff tendinopathy, 
on the basis of all that has been stated above.
Despite the very small sample of population, re-
sults are very encouraging. There was functional im-
provement (Constant Murley score) in 95% of the 
treated shoulders, while 80% reported a benefit in 
terms of pain relief. As could be expected, the best re-
sults in terms of increased functionality and less pain 
were obtained with the white plasters, the more potent 
type called “AT5.06”. 
Moreover patients showed satisfaction to use a 
device that is easy to position, water-resistant and in 
no way hinders shoulder joint movement, only needing 
replacement by medical staff after 7 days. 
Conclusions
In conclusion the use of FIT® plasters, as support 
to alleviate painful symptoms and improve function in 
rotator cuff tendinopathies, has so far been studied lit-
tle in literature, but there are preliminary studies on 
devices with these properties that have shown a certain 
effectiveness, in stimulating activation of the endog-
enous analgesic action and in particular the absence 
of adverse events. On the base of the safety of this 
technology and promising results of our study, further 
studies should be encouraged to confirm its effective-
ness, increasing the sample number and follow up so as 
to demonstrate definitely that the use of technologies, 
on which FIT® plasters is based, may be a valid alter-
native as “non-medicated pain relief”.
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